Mometasone Furoate

Overview

Mometasone Furoate is a synthetic corticosteroid with anti-inflammatory and antipruritic properties. It is commonly used in the treatment of skin conditions and allergic rhinitis.

API suppliers (23)

Suppliers of Mometasone Furoate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• AARTI PHARMALABS LIMITEDIndia4 active DMF
• Cipla USA, Inc.USA2 active DMF
• SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD2 active DMF
• CORAL DRUGS PRIVATE LTD2 active DMF GMP on record
• TIANJIN TIANYAO PHARMACEUTICALS CO LTDChina2 active DMF
• NEWCHEM SPAItaly2 active DMF GMP on record
• STERLING SPAItaly2 active DMF GMP on record
• WAVELENGTH ENTERPRISES LTDIsrael2 active DMF GMP on record
• INDUSTRIALE CHIMICA SRLItaly1 active DMF GMP on record
• CORAL DRUGS PVT LTDIndia1 active DMF GMP on record
• HENAN LIHUA PHARMACEUTICAL CO LTD1 active DMF
• BREATHGREEN PHARMACEUTICAL CO LTD1 active DMF
• SYMBIOTEC PHARMALAB LTD1 active DMF GMP on record
• TAPI NL BVNetherlands1 active DMF
• SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysia1 active DMF
• Aurisco Pharmaceutical Co.,ltdChina1 active DMF GMP on record
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• Taro Pharmaceutical Industries Ltd.Israel1 active DMF GMP on record
• CURIA SPAIN SAUSpain1 active DMF GMP on record
• FARMABIOS SPAItaly1 active DMF
• Hovione FarmaCiencia SAPortugal1 active DMF GMP on record
• SYMBIOTEC PHARMALAB PRIVATE LTDIndia1 active DMF GMP on record
• HUNAN YUXIN PHARMACEUTICAL CO LTD

Patent & exclusivity (US)

Per the FDA Orange Book (20 approved US products), the latest listed US patent on Mometasone Furoate expires 24 Nov 2034. Generic API sourcing typically opens up once these lapse.

Therapeutic areas